Der findes ingen kontrollerede epidemiologiske data vedrørende risikoen med Angiotensin II- Receptor - Antagonister (AIIRAer), men lignende risici kan findes for denne lægemiddelgruppe. ###>Whilst there is no controlled epidemiological data on the risk with Angiotensin II Receptor Antagonists (AIIRAs), similar risks may exist for this class of drugs.